{"id":"chlorhexidine-mupirocin","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation"},{"rate":null,"effect":"Contact dermatitis"},{"rate":null,"effect":"Erythema"},{"rate":null,"effect":"Pruritus"}]},"_chembl":{"chemblId":"CHEMBL1628","moleculeType":"Small molecule","molecularWeight":"701.61"},"_dailymed":{"setId":"a83a55e8-58df-ac57-e053-2a95a90a9425","title":"NUSURGEPAK SURGICAL PREP/CAREPAK (CHLORHEXIDINE GLUCONATE, MUPIROCIN, DIMETHICONE) KIT [NUCARE PHARMACEUTICALS INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Chlorhexidine is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, while mupirocin inhibits bacterial isoleucyl-tRNA synthetase, blocking protein synthesis. Together, they provide synergistic antimicrobial activity against a wide range of gram-positive and gram-negative bacteria, making them effective for topical infection prevention and treatment.","oneSentence":"This combination of chlorhexidine and mupirocin works by disrupting bacterial cell membranes and inhibiting bacterial protein synthesis to prevent and treat skin infections.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T05:59:48.182Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Skin and soft tissue infection prevention and treatment"},{"name":"Surgical site infection prophylaxis"},{"name":"Wound care and management"}]},"trialDetails":[{"nctId":"NCT06397781","phase":"PHASE4","title":"Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2031-01-01","conditions":"Atopic Dermatitis","enrollment":100},{"nctId":"NCT02572791","phase":"PHASE4","title":"Staph Household Intervention for Eradication (SHINE)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-10","conditions":"Skin and Subcutaneous Tissue Bacterial Infections, Staphylococcus Aureus, MRSA - Methicillin Resistant Staphylococcus Aureus Infection","enrollment":835},{"nctId":"NCT03489629","phase":"PHASE2","title":"STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-04-03","conditions":"Cystic Fibrosis","enrollment":37},{"nctId":"NCT06712433","phase":"PHASE2","title":"Bacterial Decolonization Plus Intraoperative Angiography for Soft Tissue Sarcomas Receiving Preoperative Radiotherapy (CONCERTO)","status":"NOT_YET_RECRUITING","sponsor":"Adam Olson","startDate":"2026-09-30","conditions":"Sarcoma,Soft Tissue","enrollment":31},{"nctId":"NCT06378359","phase":"","title":"Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-01-29","conditions":"Staphylococcus Aureus Colonization, Surgical Site Infections, Healthcare Associated Infections","enrollment":250},{"nctId":"NCT06210594","phase":"PHASE4","title":"Staph Intervention for Effective Local Defense","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2024-04-01","conditions":"Staphylococcus Aureus Infection","enrollment":78},{"nctId":"NCT06541145","phase":"NA","title":"Bacterial Decolonization Within Dyads","status":"RECRUITING","sponsor":"Duke University","startDate":"2024-08-21","conditions":"Bacterial Colonization","enrollment":20},{"nctId":"NCT07142408","phase":"PHASE3","title":"The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal","status":"RECRUITING","sponsor":"The Cooper Health System","startDate":"2023-03-13","conditions":"Surgical Wound Infection","enrollment":848},{"nctId":"NCT05586776","phase":"PHASE4","title":"Decolonization to Reduce After-Surgery Events of Surgical Site Infection","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-01-17","conditions":"Surgical Site Infection","enrollment":2700},{"nctId":"NCT06633588","phase":"PHASE4","title":"Decolonization Efficacy of Polyhexanide vs. Mupirocin","status":"RECRUITING","sponsor":"Swiss Paraplegic Research, Nottwil","startDate":"2025-05-01","conditions":"Staphylococcus Aureus, Colonization, Asymptomatic","enrollment":24},{"nctId":"NCT03140423","phase":"PHASE4","title":"Mupirocin-Iodophor ICU Decolonization Swap Out Trial","status":"COMPLETED","sponsor":"Harvard Pilgrim Health Care","startDate":"2017-05-01","conditions":"Staphylococcus Aureus","enrollment":353323},{"nctId":"NCT00532324","phase":"NA","title":"A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA","status":"COMPLETED","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2008-02","conditions":"Staphylococcus Aureus","enrollment":107},{"nctId":"NCT00560599","phase":"PHASE3","title":"A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection","status":"COMPLETED","sponsor":"loren g miller","startDate":"2007-04","conditions":"Methicillin Resistant Staphylococcus Aureus Skin Infections","enrollment":350},{"nctId":"NCT02945722","phase":"PHASE4","title":"Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2018-02-23","conditions":"Hemodialysis Patients","enrollment":434},{"nctId":"NCT05505214","phase":"PHASE2","title":"Topical Steroids & Bacterial Decolonization for Radiation Dermatitis","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2023-09-01","conditions":"Radiation Dermatitis","enrollment":""},{"nctId":"NCT03883828","phase":"PHASE2, PHASE3","title":"Bacterial Decolonization to Prevent Radiation Dermatitis","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2019-06-03","conditions":"Radiation Dermatitis","enrollment":80},{"nctId":"NCT04218799","phase":"PHASE4","title":"Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2014-08-12","conditions":"Human Microbiome","enrollment":19},{"nctId":"NCT04285697","phase":"NA","title":"Infection Prevention Bundle in Brain Tumor Surgery","status":"SUSPENDED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2020-02-20","conditions":"Surgical Site Infection, Brain Tumor","enrollment":300},{"nctId":"NCT03173053","phase":"NA","title":"S. Aureus Decolonization in HPN Patients.","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2018-02-08","conditions":"Staphylococcus Aureus, Motility Disorder","enrollment":63},{"nctId":"NCT02223520","phase":"NA","title":"Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-11","conditions":"Staph Aureus Colonization, Staph Aureus Infection","enrollment":307},{"nctId":"NCT02216227","phase":"NA","title":"Checklist to Prevent MRSA Surgical Site Infections","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2014-04-01","conditions":"Surgical Site Infection","enrollment":1794},{"nctId":"NCT03962907","phase":"PHASE4","title":"Preoperative Decolonization and Surgical Site Infections in Orthopaedic Surgery - 2 Year Outcome in Prosthetic Surgery","status":"COMPLETED","sponsor":"Lindenhofgruppe AG","startDate":"2019-01-01","conditions":"Staphylococcus Aureus, Orthopaedic Surgery, Surgical Site Infection","enrollment":1318},{"nctId":"NCT04222699","phase":"PHASE4","title":"Cultures Before and After Decolonization in Community Dwelling Adults With Current S. Aureus Colonization","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2012-09-18","conditions":"Human Microbiome","enrollment":58},{"nctId":"NCT01138462","phase":"NA","title":"Control of MRSA in Nursing Homes: Decolonization vs Standard Precautions","status":"COMPLETED","sponsor":"University of Lausanne Hospitals","startDate":"2010-06","conditions":"Methicillin-Resistant Staphylococcus Aureus","enrollment":157},{"nctId":"NCT01438515","phase":"NA","title":"Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization","status":"COMPLETED","sponsor":"Horizon Health Network","startDate":"2008-08","conditions":"Methicillin-resistant Staphylococcus Aureus","enrollment":100},{"nctId":"NCT02182115","phase":"PHASE4","title":"S. Aureus Screening and Decolonization","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2014-07","conditions":"Wound Infection Due to Staphylococcus Aureus, MRSA Infection of Postoperative Wound","enrollment":110},{"nctId":"NCT01302210","phase":"","title":"Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities","status":"COMPLETED","sponsor":"Endeavor Health","startDate":"2010-10","conditions":"Methicillin Resistant Staphylococcus Aureus","enrollment":22302},{"nctId":"NCT02547103","phase":"PHASE4","title":"Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2016-06-01","conditions":"End Stage Renal Disease, Peritoneal Dialysis","enrollment":354},{"nctId":"NCT02063867","phase":"NA","title":"Active Bathing to Eliminate Infection (ABATE Infection) Trial","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2014-04","conditions":"Healthcare Associated Infections, Methicillin Resistant Staphylococcus Aureus, Multi Drug Resistant Organisms","enrollment":53},{"nctId":"NCT00966446","phase":"NA","title":"Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-09","conditions":"MRSA - Methicillin Resistant Staphylococcus Aureus Infection","enrollment":223},{"nctId":"NCT01594827","phase":"PHASE2","title":"Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Cystic Fibrosis","enrollment":29},{"nctId":"NCT02029872","phase":"PHASE4","title":"Stop Community MRSA Colonization Among Patients","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-01","conditions":"MRSA","enrollment":77},{"nctId":"NCT02560155","phase":"NA","title":"Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial","status":"COMPLETED","sponsor":"Lindenhofgruppe AG","startDate":"2015-11","conditions":"Orthopedic Disorders, Surgical Site Infection","enrollment":1300},{"nctId":"NCT02566928","phase":"PHASE4","title":"Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence","status":"UNKNOWN","sponsor":"Clinical Directors Network","startDate":"2015-10","conditions":"Methicillin-Resistant Staphylococcus Aureus, Recurrence, Staphylococcal Skin Infections","enrollment":278},{"nctId":"NCT03081962","phase":"PHASE3","title":"Effect of a Combination of Bundles on Surgical-site Infection After Elective Colorectal Surgery","status":"UNKNOWN","sponsor":"Hospital General Universitario Elche","startDate":"2017-02-15","conditions":"Surgical Site Infection","enrollment":102},{"nctId":"NCT01349192","phase":"PHASE2","title":"Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2011-04","conditions":"Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus","enrollment":47},{"nctId":"NCT00980980","phase":"NA","title":"Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)","status":"COMPLETED","sponsor":"Harvard Pilgrim Health Care","startDate":"2009-09","conditions":"Methicillin-resistant Staphylococcus Aureus","enrollment":74256},{"nctId":"NCT01537783","phase":"PHASE4","title":"Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2011-09","conditions":"Cutaneous Abscess","enrollment":50},{"nctId":"NCT00513799","phase":"NA","title":"The Natural History of Community-Associated MRSA Infections and Decolonization Strategies","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2007-03","conditions":"Abscesses, Furunculosis, Staphylococcus Aureus","enrollment":300},{"nctId":"NCT01820455","phase":"NA","title":"MRSA in a Trauma Population: Does Decolonization Prevent Infection?","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2012-01","conditions":"MRSA Colonization","enrollment":55},{"nctId":"NCT01918813","phase":"NA","title":"Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening","status":"COMPLETED","sponsor":"Chikara Tashiro","startDate":"2009-11","conditions":"Inflammatory Bowel Disease, Hepatobiliary Disease, Pancreas Disease","enrollment":662},{"nctId":"NCT01400308","phase":"PHASE4","title":"Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA)","status":"TERMINATED","sponsor":"B. Braun Medical SA","startDate":"2010-02","conditions":"MRSA - Methicillin Resistant Staphylococcus Aureus Infection, MRSA Colonization","enrollment":99},{"nctId":"NCT01232231","phase":"NA","title":"Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting","status":"COMPLETED","sponsor":"Joseph Kim","startDate":"2010-07","conditions":"Methicillin-resistant Staphylococcus Aureus","enrollment":15},{"nctId":"NCT00731783","phase":"NA","title":"Staphylococcus Aureus Decolonization Study","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2008-07","conditions":"Staphylococcal Skin Infections, Abscesses, Furunculosis","enrollment":183}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":338,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Hibiclens","Bactroban"],"phase":"marketed","status":"active","brandName":"Chlorhexidine, Mupirocin","genericName":"Chlorhexidine, Mupirocin","companyName":"University of Tennessee","companyId":"university-of-tennessee","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination of chlorhexidine and mupirocin works by disrupting bacterial cell membranes and inhibiting bacterial protein synthesis to prevent and treat skin infections. Used for Skin and soft tissue infection prevention and treatment, Surgical site infection prophylaxis, Wound care and management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}